Clinical Trial Update: Clinical Studies of Gemcitabine-Oxaliplatin [Phase 2]

View source ↗

Summary

Phase 2 clinical studies of a gemcitabine-oxaliplatin regimen for pediatric central nervous system tumors, including medulloblastoma, have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Tumors
• Medulloblastoma
• Neuroblastoma
• Osteosarcoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Medulloblastoma, Central Nervous System Tumors | Phase 2 | Status: COMPLETED